Background: Spinosin, a major component of Semen Zizhiphi Spinosae, has been shown to modulate sedation and hypnosis; however, the underlying neuronal mechanisms of its stimulatory effects remain unclear.
INTRODUCTION
Zizyphi Spinosi Semen is a traditional tranquilizing medicine that has been extensively employed for the treatment of insomnia [1, 2] . Spinosin, which is one of the major components of Semen Zizhiphi Spinosae, has been shown to significantly potentiate the hypnotic effects of pentobarbital in mice at both 10 and 15 mg/kg by decreasing sleep latency, increasing sleep time, and increasing the rate of sleep onset induced by a subhypnotic dose of pentobarbital [3] . Spinosin exerted an anxiolytic-like effect at 5 mg/kg in the elevated plus maze, light/dark box test, and open field test of mice [4] . . In addition, the application of spinosin (15mg/kg) to pentobarbital-treated rats significantly induces rapid eye movement (REM) sleep through the postsynaptic serotonin 1A(5-HT1A) receptors [5] , but whether spinosin-inducing sleep is mediated via 5-HT1A receptors remains unclear. Spinosin also induces sleep by disrupting the wake-generating systems or by increasing the activity of sleep-promoting systems.
To identify the neuronal populations and pathways by which spinosin enhances sedation and hypnosis, mice were injected with spinosin (15 mg/kg), and then neuronal activation patterns in the sleep-arousal brain areas-including the accumbens (Acb) nucleus, vertical limb of the diagonal band (VDB) nucleus, horizontal limb of the diagonal band (HDB) nucleus, ventrolateral preoptic area (VLPO), lateral hypothalamic area (LHA), ventral tuberomammillary (VTM) nucleus, ventral tegmental area (VTA), dorsal raphe (DR) nucleus, and locus coeruleus (LC)-were assessed using single c-Fos immunohistochemistry followed by dual immunostaining for c-Fos and transmitter-specific markers in the neurons of sleep-arousal brain areas based on single c-Fos immunohistochemical positive results in the sleep-arousal brain.
MATERIALS AND METHODS

Animals
Ten pathogen-free adult male mice (Shanghai SLAC Laboratory Animal Co., Ltd., China) with weights within the range of 24 to 28 g were maintained in a room with conditions of 20°C-22°C and light-regulated conditions (12 h light starting at 0700 h).
The mice were provided ad libitum access to food and water. The experiment was performed after allowing the animals to acclimate to the laboratory conditions for at least 1 week. All efforts were made to minimize the number of animals utilized in this study and any pain and discomfort experienced by the mice. The protocol for animal handling was approved and followed the animal guidelines established by the Laboratory Animal Research Center of Zhejiang Chinese Medical University, Hangzhou, in Zhejiang province.
Spinosin injection procedures and tissue preparation
The mice were maintained in cages throughout the entire experiment, except when they received spinosin or saline injection. Five mice were injected i.p. with 15 mg/kg of spinosin (National Institutes for Food and Drug Control, China; purity: 95.4%) or saline.
The spinosin doses were selected based on previous studies [3, 5] , which consistently showed that spinosin administered i.p. at a concentration of 15 mg/kg generated a significant increase in sleep time. Spinosin was mixed in a sterile saline solution at a dose of 15 mg/mL, and the mice were injected with a volume of 1 mL/kg body weight (BW). The injections were administered at 1900 h. After injection, the mice were immediately placed back in their cages, and their behavior was monitored every 30 min.
Approximately 90 min after injection, the mice were subjected to anesthesia using chloral hydrate (500 mg/kg, i.p.). Upon confirmation that the mice were unresponsive to tail-or foot-pinching, they were perfused with saline and then fixed with 4% paraformaldehyde. After perfusion at 4°C for 2 h, their brains were isolated, post-fixed overnight in the same fixative, and then transferred to 20% sucrose. Three sets of 30-μm sections were prepared using a Leica freezing microtome (Leica, type 820-II) at the coronal plane, mounted in a cryoprotectant solution, and the stored at −20°C until immunohistochemical staining.
Immunohistochemical procedures
The first set of stored free-floating tissue sections was rinsed in phosphate buffered saline (PBS), washed with 3% H2O2 in PBS for 30 min, blocked with 5% goat serum 
Cell counts
The pattern of c-Fos immunoreactivity within the major brain regions of the sleep-arousal system and other brain regions showed significant changes after treatment with spinosin. The sections were assessed, and images were captured using an Olympus IX71 microscope equipped with fluorescent and bright-field optics. We employed Adobe Photoshop CS2 in post-processing the digital photomicrographs as well as in preparing the schematic illustrations. Adjustment of sharpness, color balance, and contrast was performed to obtain an optimal match of immunohistochemically stained cells against the background. The anatomical landmarks and abbreviations employed in this study were based on a mouse brain atlas [6] . The outlines of the sections and major structures were evaluated at low magnification (4×), followed by 
Data analysis
The results of this study are presented as the mean ± standard error of the mean (SEM). These ratios are shown as the percentage of the orexin or TH cell populations that was doubled-stained for c-Fos. We used the paired t test to detect differences, and P-values < 0.05 were deemed statistically significant.
RESULTS
c-Fos immunoreactivity in major brain areas of the mouse sleep-arousal system after injecting spinosin or saline
The number of cells that were immunopositive for c-Fos was determined in the sleep-arousal brain regions, including Acb, VDB, HDB, VLPO, LHA, VTM, VTA, DR, as well as LC ( Figs. 1 and 2 ). There were no statistically significant differences in the number of c-Fos-IR neurons in the Acb and VLPO and decreases in the number of c-Fos-IR in the VDB, HDB, VTM, VTA, and DR between saline and spinosin-injected mice ( Table 1 ). The LHA and LC of saline-treated mice contained a large number of c-Fos-IR, while c-Fos expression was markedly decreased in the LHA and LC following injection of spinosin into mice (P < 0.01, Table 1 ).
Spinosin inhibits c-Fos + /orexin + expression in the LHA
The orexin neurons within the LHA are generally active when an animal is awake, particularly during motor activity as the animal actively explores its immediate environment. The noradrenergic cell groups of the LC are major components comprising the ascending arousal system. We next aimed to examine the expression of c-Fos + /orexin + in the LHA and c-Fos + /TH + (noradrenergic neuron marker) in the LC following injection of spinosin and saline into mice. Unlike saline, spinosin inhibited the expression of c-Fos + /orexin + in the LHA (Fig. 3 ). c-Fos + /TH + expression was not observed within the LC (Fig. 4 ). Paired t test analysis indicated that LHA c-Fos + /orexin + expression was significantly lower after spinosin injection compared to saline injection (P < 0.01) ( Fig. 5 ). 
DISCUSSION
Methodological assessment
c-Fos immunohistochemistry detects the activation of specific neurons activated in response to different experimental conditions; however, this technique is also associated with certain limitations. c-Fos expression is induced by an increase in cAMP or calcium levels, which commonly occur upon synaptic activation [7] . However, not all activated neurons express c-Fos, and cells that are inhibited might not express c-Fos [8, 9] .
Spinosin may influence neuronal populations that are often overlooked by immunohistochemistry. This approach enables the analysis of the correlation between neuronal activity and behavioral state, although we were unable to determine whether c-Fos expression in the LHA and LC that was inhibited by spinosin was the cause or the consequence of sleep. Further investigations on lesions in the LHA and LC in mice may further assess whether the LHA and LC neurons are essential to spinosin-induced sedation and hypnosis. Here, c-Fos in the Acb, VDB, HDB, and VLPO did not exhibit a significant increase in immunoreactivity after spinosin injection, even though these regions remain active during sleep. The mechanism underlying the lack of substantial increases in c-Fos expression remains unclear, although neuronal discharge patterns and the recruitment of certain intracellular signaling pathways could contribute to c-Fos induction. The present study employed intraperitoneal injections of spinosin to avoid cannula injury, as trauma-induced c-Fos usually occurs within 200 Wm of the cannula track [10] . Furthermore, the number of c-Fos-IR nuclei in certain brain areas may vary extensively among consecutive sections due to size or shape variations within a cell group. Thus, for each brain region, bilateral cell counts using 10 consecutive sections were conducted to minimize sampling error. During our visualization of double immunostaining of c-Fos and orexin/noradrenergic neurons, we were unable to distinguish whether c-Fos expression in a neuron was a direct consequence of spinosin in the neurons or an indirect result of the stimulatory effects of spinosin [11] . However, the other functions of spinosin did not coincide with the c-Fos expression patterns in the LHA and LC. Thus, in the present study, c-Fos expression in LHA orexin neurons and LC noradrenergic neurons may be the direct result of spinosin injection or the consequence of indirect activation.
c-Fos immunoreactivity patterns induced by spinosin injections
Acb, which is located within the rostrobasal forebrain, exhibits GABAergic projections toward a wide range of targets, such as the ventral pallidum (VP), the LHA, the parabrachial nucleus (PB), and the VTA, which may contribute to wakefulness [12] [13] [14] . VLPO neurons secrete inhibitory neurotransmitters, galanin, and GABA and are mainly active during sleep and send efferent projections to various major cell groups within the hypothalamus and brainstem that are involved in arousal [15, 16] . The VDB and HDB, which are located within the basal forebrain, consist of cholinergic neurons, and c-Fos immunoreactivity has been reported during wakefulness but found to be significantly lower during sleep [17, 18] . The VTM (histamine neuron), VTA (dopamine neuron), DR (serotonin), and LC (noradrenergic neuron) are major components of the ascending arousal system participating in cortical arousal [19] . LHA orexin neurons form ascending projections toward the cerebral cortex and descending projections directed to the monoaminergic and cholinergic cell groups of the arousal systems that are highly active during wakefulness [20, 21] . Here, spinosin did not induce an obvious change in c-Fos-IR neuron counts in the Acb, VLPO, VDB, HDB, VTM, VTA, and DR relative to saline. In addition, spinosin significantly decreased c-Fos expression in the LHA orexin neurons and the LC. These results indicate that spinosin induces sleep by repressing the wake-generating systems or by enhancing the activity of sleep-promoting systems.
How might spinosin induce behavioral sleep?
The aim of the present study was to determine whether the inhibition of arousal-promoting neurons or brain regions is correlated with behavioral sleep after spinosin injection. We determined that spinosin markedly downregulated c-Fos in the LHA and LC as well as in the LHA orexin neurons. 5-HT1A receptor expression was observed in serotonergic neurons as well as in LHA orexin neurons [22, 23] . The serotonergic inhibitory signals can hyperpolarize LHA orexin neurons via the 5-HT1A receptor, which is involved in the control of sleep-wakefulness states [24] . The 5-HT1A receptors are also distributed across the LC, with LC noradrenaline (NE) metabolism induced via their activation [25, 26] . The 5-HT1A receptor agonist enhanced NE metabolism in the LC, which in turn increased the firing rate of this particular brain region [27] . An earlier study revealed that spinosin (15 mg/kg, i.g.) significantly antagonizes the 5-HT1A agonist 8-OH-DPAT-induced decrease in total sleep time, NREM sleep, as well as REM sleep in pentobarbital-treated animals [5] . Furthermore, the combined treatment of spinosin and the 5-HT1A antagonist resulted in significant augmentative effects on pentobarbital-induced sleep [5] . These findings suggest that spinosin could be an antagonist to the postsynaptic 5-HT1A receptors [28] .
CONCLUSIONS
The results of the present study indicate that spinosin can impart inhibitory effects on the firing of the LHA orexin neurons and the LC neurons. This study provides important insights into the function of spinosin in regulating sedation and hypnosis. side of the brain that was averaged across animals."n" indicates the number of animals.
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